Aastrom Biosciences Inc., of Ann Arbor, Mich., appointed Ronnda Bartel as vice president of research and development.

Acusphere Inc., of Watertown, Mass., appointed Jonathan Jaffe as vice president of medical affairs.

Adherex Technologies Inc., of Research Triangle Park, N.C., appointed Michael Martin to its board.

Adventrx Pharmaceuticals Inc., of San Diego, appointed president and CEO Jack Lief to the board.

Affymax Inc., of Palo Alto, Calif., appointed Daniel Spiegelman to its board.

Amgen Inc., of Thousand Oaks, Calif., appointed Thomas Flanagan as senior vice president and chief information officer.

Amicus Therapeutics Inc., of Cranbury, N.J., appointed James Dentzer as chief financial officer.

Array BioPharma Inc., of Boulder, Colo., appointed April Teitelbaum as vice president of clinical development, oncology.

Arrowhead Research Corp., of Pasadena, Calif., appointed Edward Jacobs as president and CEO of its majority owned subsidiary, Insert Therapeutics, effective Jan. 1.

Avalon Pharmaceuticals Inc., of Germantown, Md., appointed David Muth as executive vice president and chief business officer.

BioTrove Inc., of Woburn, Mass., appointed Albert Luderer as president, CEO and board member, and appointed Edward Erickson to the board.

Cadence Pharmaceuticals Inc., of San Diego, appointed Samuel Barker to its board.

Cardax Pharmaceuticals Inc., of Aiea, Hawaii, appointed Fred Pashkow as chief medical officer.

CardioVascular BioTherapeutics Inc., of Las Vegas, appointed Mike Norris as vice president of corporate development.

Cerus Corp., of Concord, Calif., appointed William Greenman as president of Cerus Europe.

ChondroGene Ltd., of Toronto, named Heiner Dreismann to its board.

Enzo Biochem Inc., of New York, appointed Gary Cupit as president of Enzo Therapeutics Inc.

Evotec AG, of Hamburg, Germany, appointed David Brister as chief business officer.

Favrille Inc., of San Diego, appointed Michael Eagle as chairman.

Fovea Pharmaceuticals SA, of Paris, appointed Gary Jay Sternberg as senior vice president and chief business officer.

GenVec Inc., of Gaithersburg, Md., appointed Douglas Swirsky as chief financial officer, treasurer and corporate secretary.